Dagmara Dymerska

Dagmara Dymerska

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DSDiamanto Skopelitou
Diamanto Skopelitou
BMBeiping Miao
Beiping Miao
ASAayushi Srivastava
Aayushi Srivastava
AAAbhishek A0bhishek
Abhishek A0bhishek
MMMagdalena Marciniak
Magdalena Marciniak
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
Germline mutations in predisposition genes account for only 20% of all familial colorectal cancers (CRC) and the remaining genetic burden may be due to rare high- to moderate-penetrance germline variants that are not explored. With the aim of identifying such potential cancer-predisposing variants, we performed whole exome sequencing on three CRC cases and three unaffected members of a Polish family and identified two novel heterozygous variants: a coding variant in APC downregulated 1 gene (APCDD1, p.R299H) and a non-coding variant in the 5′ untranslated region (UTR) of histone deacetylase 5 gene (HDAC5). Sanger sequencing confirmed the variants segregating with the disease and Taqman assays revealed 8 additional APCDD1 variants in a cohort of 1705 familial CRC patients and no further HDAC5 variants. Proliferation assays indicated an insignificant proliferative impact for the APCDD1 variant. Luciferase reporter assays using the HDAC5 variant resulted in an enhanced promoter activity. Targeting of transcription factor binding sites of SNAI-2 and TCF4 interrupted by the HDAC5 variant showed a significant impact of TCF4 on promoter activity of mutated HDAC5. Our findings contribute not only to the identification of unrecognized genetic causes of familial CRC but also underline the importance of 5’UTR variants affecting transcriptional regulation and the pathogenesis of complex disorders.

16 January 2015 in Hereditary Cancer in Clinical Practice
Verified
Journal Article
Open access
PDF file
TDTadeusz Dębniak
Tadeusz Dębniak
TGTomasz Gromowski
Tomasz Gromowski
Rodney ScottRodney Scott
Rodney Scott
JGJacek Gronwald
Jacek Gronwald
THTomasz Huzarski
Tomasz Huzarski
JLJan Lubiński
Jan Lubiński
Over half the cancer deaths in HNPCC families are due to extra-colonic malignancies that include endometrial and ovarian cancers. The benefits of surveillance for gynecological cancers are not yet proven and there is no consensus on the optimal surveillance recommendations for women with MMR mutations. We performed a systematic review of the literature and evaluated gynecological cancer risk in a series of 631 Polish HNPCC families classified into either Lynch Syndrome (LS, MMR mutations detected) or HNPCC (fulfillment of the Amsterdam or modified Amsterdam criteria). Published data clearly indicates no benefit for ovarian cancer screening in contrast to risk reducing surgery. We confirmed a significantly increased risk of OC in Polish LS families (OR = 4,6, p < 0.001) and an especially high risk of OC was found for women under 50 years of age: OR = 32,6, p < 0.0001 (95% CI 12,96-81,87). The cumulative OC risk to 50 year of life was calculated to be 10%. Six out of 19 (32%) early-onset patients from LS families died from OC within 2 years of diagnosis. We confirmed a significantly increased risk of EC (OR = 26, 95% CI 11,36-58,8; p < 0,001). The cumulative risk for EC in Polish LS families was calculated to be 67%. Due to the increased risk of OC and absence of any benefit from gynecological screening reported in the literature it is recommended that prophylactic oophorectomy for female carriers of MMR mutations after 35 year of age should be considered as a risk reducing option. Annual transvaginal ultrasound supported by CA125 or HE4 marker testing should be performed after prophylactic surgery in these women. Due to the high risk of EC it is reasonable to offer, after the age of 35 years, annual clinical gynecologic examinations with transvaginal ultrasound supported by routine aspiration sampling of the endometrium for women from either LS or HNPCC families. An alternative option, which could be taken into consideration for women preferring surgical prevention, is risk reducing total hysterectomy (with bilateral salpingo-oophorectomy) for carriers after childbearing is complete.

4 December 2012 in Hereditary Cancer in Clinical Practice
Verified
Journal Article
Open access
PDF file
GKGrzegorz Kurzawski
Grzegorz Kurzawski
DDDagmara Dymerska
Dagmara Dymerska
PSPablo Serrano-Fernández
Pablo Serrano-Fernández
JTJoanna Trubicka
Joanna Trubicka
BMBartłomiej Masojć
Bartłomiej Masojć
Rodney ScottRodney Scott
Rodney Scott
During the past decade many new molecular methods for DNA and RNA analysis have emerged. The most popular thus far have been SSCP, HET, CMC, DGGE, RFLP or ASA, which have now been replaced by methods that are more cost effective and less time consuming. Real-time amplification techniques and particularly those with the capacity of multiplexing have become commonly used in laboratory practice. Novel screening methods enable the very rapid examination of large patients series. Use of liquid handling robotics applied to the isolation of DNA or RNA, the normalisation of sample concentration, and standardization of target amplification by PCR have also contributed to a reduced risk of sample contamination and have resulted in laboratory analysis being easier and faster. The aim of this study is the introduction of a few modern techniques, most commonly used in detection of genetic predisposition to cancer.

3 August 2017 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
DDDagmara Dymerska
Dagmara Dymerska
KGKatarzyna Gołębiewska
Katarzyna Gołębiewska
MMMagdalena Marciniak
Magdalena Marciniak
HRHelena Rudnicka
Helena Rudnicka
RSRodney J Scott
Rodney J Scott
GKGrzegorz Kurzawski
Grzegorz Kurzawski

5 September 2013 in Clinical Genetics
Verified
Journal Article
Open access
PDF file
DDDagmara Dymerska
Dagmara Dymerska
GKG. Kurzawski
G. Kurzawski
JSJ. Suchy
J. Suchy
HRH. Roomere
H. Roomere
KTK. Toome
K. Toome
JLJan Lubiński
Jan Lubiński

13 May 2022 in Molecular Genetics and Genomics
Verified
Journal Article
Open access
PDF file
DSDiamanto Skopelitou
Diamanto Skopelitou
ASAayushi Srivastava
Aayushi Srivastava
BMBeiping Miao
Beiping Miao
AAAbhishek A0bhishek
Abhishek A0bhishek
DDDagmara Dymerska
Dagmara Dymerska
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
About 15% of colorectal cancer (CRC) patients have first-degree relatives affected by the same malignancy. However, for most families the cause of familial aggregation of CRC is unknown. To identify novel high-to-moderate-penetrance germline variants underlying CRC susceptibility, we performed whole exome sequencing (WES) on four CRC cases and two unaffected members of a Polish family without any mutation in known CRC predisposition genes. After WES, we used our in-house developed Familial Cancer Variant Prioritization Pipeline and identified two novel variants in the solute carrier family 15 member 4 (SLC15A4) gene. The heterozygous missense variant, p. Y444C, was predicted to affect the phylogenetically conserved PTR2/POT domain and to have a deleterious effect on the function of the encoded peptide/histidine transporter. The other variant was located in the upstream region of the same gene (GRCh37.p13, 12_129308531_C_T; 43 bp upstream of transcription start site, ENST00000266771.5) and it was annotated to affect the promoter region of SLC15A4 as well as binding sites of 17 different transcription factors. Our findings of two distinct variants in the same gene may indicate a synergistic up-regulation of SLC15A4 as the underlying genetic cause and implicate this gene for the first time in genetic inheritance of familial CRC.